Research Article
The Influence of Socioeconomic Status on Racial/Ethnic Disparities among the ER/PR/HER2 Breast Cancer Subtypes
Table 2
Five-year survival of the eight ER/PR/HER2 subtypes
.
| ER/PR/HER2 | | % | 5-year survival | 95% CI |
| ER+/PR+/HER2− | 83,169 | 58.09% | 94.95% | (94.86%, 95.12%) | ER+/PR+/HER2+ | 13,293 | 9.28% | 92.00% | (91.73%, 92.52%) | ER+/PR−/HER2− | 13,363 | 9.33% | 89.58% | (89.27%, 90.17%) | ER+/PR−/HER2+ | 4,535 | 3.17% | 87.87% | (87.31%, 88.96%) | ER−/PR+/HER2− | 1,131 | 0.79% | 83.68% | (82.46%, 86.08%) | ER−/PR+/HER2+ | 539 | 0.38% | 85.53% | (83.85%, 88.83%) | ER−/PR−/HER2− | 18,299 | 12.78% | 78.78% | (78.44%, 79.45%) | ER−/PR−/HER2+ | 8,855 | 6.18% | 81.11% | (80.65%, 82.02%) |
| Total | 143,184 | | | |
|
|
Survival for all subtypes statistically significantly worse (Log-Rank test ) than the ER+/PR+/HER2− subtype.
|